Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life
Nissenson, A.R.
Seminars in Nephrology 9(1 Suppl 2: 25-31
1989
ISSN/ISBN: 0270-9295 PMID: 2669083 Document Number: 334002
The clinical manifestations of uremia are only incompletely reversed by chronic hemodialysis. Signs and symptoms can include abnormalities in electrophysiologic indices, clinical mental status, and neuropsychological test performance, as well as decreases in exercise tolerance, sexual potency, and general quality of life. Though retention of uremic toxins is responsible for many of these symptom complexes, some may be caused, or substantially aggravated, by the anemia that almost invariably accompanies chronic renal failure. Treatment with recombinant human erythropoietin (r-HuEPO; EPOGEN , AMGEN Inc, Thousand Oaks, CA) increases hematocrit values and thus reduces the anemia, in turn improving brain and cognitive function, exercise tolerance, sexual potency, and quality of life.